药械指南

订阅

MedSci主页 / 所有栏目 / 药械指南

FDA干眼病治疗药物开发指南（草案） 2020

2020-10-22 美国食品和药品监督管理局 FDA

干眼病

FDA干眼病治疗药物开发指南

中文标题：

FDA干眼病治疗药物开发指南（草案） 2020

英文标题：

Dry Eye: Developing Drugs for Treatment Guidance for Industry

发布机构：

美国食品和药品监督管理局

发布日期：

2020-10-22

简要介绍：

FDA干眼病治疗药物开发指南

下载附件：
点击下载

(因为版权问题，不支持下载)

评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1082982, encodeId=27b41082982c2, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XD5jW9kdEoAPSyJpVjnKVMLJib6cuibmuBo8FheSKKdOeicx8FmO4AysFUuP0t31rtkC1cW3N7Jfibbg63oJotqXAQ/132, createdBy=32942411953, createdName=蔓荆子, createdTime=Wed Dec 22 10:05:48 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003885, encodeId=ca3f1003885fb, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44565409552, createdName=纪芳, createdTime=Fri Jul 30 15:08:16 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947997, encodeId=dfeb94e997fd, content=想学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210314/f876cc88ef194e2da08c0f66ce678ab1/cb673c54ea2948139c76d869c116f07b.jpg, createdBy=07525468833, createdName=ms4000001598728459, createdTime=Sun Mar 14 08:22:57 CST 2021, time=2021-03-14, status=1, ipAttribution=)]
    2021-12-22 蔓荆子

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1082982, encodeId=27b41082982c2, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XD5jW9kdEoAPSyJpVjnKVMLJib6cuibmuBo8FheSKKdOeicx8FmO4AysFUuP0t31rtkC1cW3N7Jfibbg63oJotqXAQ/132, createdBy=32942411953, createdName=蔓荆子, createdTime=Wed Dec 22 10:05:48 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003885, encodeId=ca3f1003885fb, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44565409552, createdName=纪芳, createdTime=Fri Jul 30 15:08:16 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947997, encodeId=dfeb94e997fd, content=想学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210314/f876cc88ef194e2da08c0f66ce678ab1/cb673c54ea2948139c76d869c116f07b.jpg, createdBy=07525468833, createdName=ms4000001598728459, createdTime=Sun Mar 14 08:22:57 CST 2021, time=2021-03-14, status=1, ipAttribution=)]
    2021-07-30 纪芳

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1082982, encodeId=27b41082982c2, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/XD5jW9kdEoAPSyJpVjnKVMLJib6cuibmuBo8FheSKKdOeicx8FmO4AysFUuP0t31rtkC1cW3N7Jfibbg63oJotqXAQ/132, createdBy=32942411953, createdName=蔓荆子, createdTime=Wed Dec 22 10:05:48 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003885, encodeId=ca3f1003885fb, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44565409552, createdName=纪芳, createdTime=Fri Jul 30 15:08:16 CST 2021, time=2021-07-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947997, encodeId=dfeb94e997fd, content=想学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210314/f876cc88ef194e2da08c0f66ce678ab1/cb673c54ea2948139c76d869c116f07b.jpg, createdBy=07525468833, createdName=ms4000001598728459, createdTime=Sun Mar 14 08:22:57 CST 2021, time=2021-03-14, status=1, ipAttribution=)]
    2021-03-14 ms4000001598728459

    想学习

    0